Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

TPEX:3218 Revenue

Universal Vision Biotechnology had revenue of 1.13B TWD in the quarter ending June 30, 2026, with 10.12% growth. This brings the company's total for the last twelve months to 4.27B, up 0.24% year-over-year. In the year 2025, Universal Vision Biotechnology had annual revenue of 4.20B, down -0.57%. That makes Universal Vision Biotechnology the 20,702nd largest company in the world by revenue and 812th in Taiwan.

• Revenue (ttm): 4.27B
• Revenue Growth: +0.24%
• P/S Ratio: 2.51
• Revenue / Employee: 10.66M
• Employees: 401
• Market Cap: 10.72B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Operations Department 3.26B 74.9%
• Optical Operation Department 1.09B 25.1%

By Geography

Chart

• Taiwan 3.72B 88.5%
• Mainland China 485.05M 11.5%

Fiscal year ended Dec 31, 2025 See the full TPEX:3218 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.20B	-24.22M	-0.57%
Dec 31, 2024	4.23B	146.05M	3.58%
Dec 31, 2023	4.08B	588.20M	16.83%
Dec 31, 2022	3.49B	862.26M	32.76%
Dec 31, 2021	2.63B	578.66M	28.18%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error